These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12413945)

  • 1. Resistance to mitochondrial- and Fas-mediated apoptosis in human leukemic cells with acquired resistance to 9-beta-D-arabinofuranosylguanosine.
    Månsson E; Stridh H; Albertioni F
    Biochem Biophys Res Commun; 2002 Nov; 298(3):338-44. PubMed ID: 12413945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity.
    Lotfi K; Månsson E; Peterson C; Eriksson S; Albertioni F
    Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line.
    Nishi R; Yamauchi T; Negoro E; Takemura H; Ueda T
    Cancer Sci; 2013 Apr; 104(4):502-7. PubMed ID: 23320492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L).
    Wang Z; Wang S; Dai Y; Grant S
    J Pharmacol Exp Ther; 2002 May; 301(2):568-77. PubMed ID: 11961058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line.
    Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T
    BMC Cancer; 2014 Jul; 14():547. PubMed ID: 25070259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial-mediated mechanism.
    Gajate C; An F; Mollinedo F
    Clin Cancer Res; 2003 Apr; 9(4):1535-45. PubMed ID: 12684430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).
    Umansky V; Ushmorov A; Ratter F; Chlichlia K; Bucur M; Lichtenauer A; Rocha M
    Int J Oncol; 2000 Jan; 16(1):109-17. PubMed ID: 10601555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01).
    Tang L; Boise LH; Dent P; Grant S
    Biochem Pharmacol; 2000 Nov; 60(10):1445-56. PubMed ID: 11020446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S; Ng CP; Bonavida B
    Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H; Bouchon A; Stahl H; Krammer PH
    Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
    Wu CH; Rastegar M; Gordon J; Safa AR
    Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine.
    Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T
    Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways.
    Bhattacharya K; Samanta SK; Tripathi R; Mallick A; Chandra S; Pal BC; Shaha C; Mandal C
    Biochem Pharmacol; 2010 Feb; 79(3):361-72. PubMed ID: 19751707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori.
    Maeda S; Yoshida H; Mitsuno Y; Hirata Y; Ogura K; Shiratori Y; Omata M
    Gut; 2002 Jun; 50(6):771-8. PubMed ID: 12010877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to Ara-C up-regulates the activation of NF-kappaB, telomerase activity and Fas expression in NALM-6 cells.
    Kanno S; Hiura T; Shouji A; Osanai Y; Ujibe M; Ishikawa M
    Biol Pharm Bull; 2007 Nov; 30(11):2069-74. PubMed ID: 17978477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
    Wang S; Wang Z; Grant S
    Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
    Poulaki V; Mitsiades N; Romero ME; Tsokos M
    Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.
    Kim CN; Wang X; Huang Y; Ibrado AM; Liu L; Fang G; Bhalla K
    Cancer Res; 1997 Aug; 57(15):3115-20. PubMed ID: 9242435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance.
    Kojima H; Endo K; Moriyama H; Tanaka Y; Alnemri ES; Slapak CA; Teicher B; Kufe D; Datta R
    J Biol Chem; 1998 Jul; 273(27):16647-50. PubMed ID: 9642215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.